IDEAYA Secures $345M to Boost Cancer Research

IDEAYA Biosciences just wrapped up a big sale of its stock, raking in approximately $345 million in total. They sold a bunch of shares at $27 each and even offered some pre-funded warrants, which practically sold out thanks to a strong interest from investors. This means they're now swimming in cash to fuel their cancer-fighting research. What does it mean for you? If you're into biotech or investing, this is a sign that IDEAYA is gearing up to make some serious moves in the world of cancer treatment. Keep an eye on their progress — they might just come up with the next big thing in medicine.